stephen f. brockmeier, md · knee. 2. to critically review the current literature and ... speaker...
TRANSCRIPT
![Page 1: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/1.jpg)
Stephen F. Brockmeier, MDAssociate Professor, Orthopaedic Surgery
University of VirginiaTeam Physician UVA Athletics
ACSM/AMSSM/AOSSM Advanced Team Physician Course
December 8-11, 2016San Diego, CA
![Page 2: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/2.jpg)
Learning Objectives
1. To review prevalence of, presentation of, and management strategies for osteochondritisdissecans and focal chondral lesions in the knee.
2. To critically review the current literature and evidence and potential research avenues to improve team physicians’ abilities to appropriately and safely treat knee OCD.
![Page 3: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/3.jpg)
University of Virginia Orthopaedic Surgery
Consultant – Zimmer Biomet, MicroAire Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing Agreement/Royalties – Springer Research Grant – Arthrex Fellowship Grant – DJO, Depuy Mitek, Arthrex, Editorial Board – TSES, OJSM Board/Committee Appointments – AOSSM
Disclosures
![Page 4: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/4.jpg)
OCD Introduction
• Etiology—Trauma/Microtrauma• JOCD => AOCD• Symptoms—Pain, Swelling,
Mechanical• Diagnosis—PE, Radiographs,
MRI• Treatment—Individualized• Adult Chondral Injuries
![Page 5: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/5.jpg)
University of Virginia Orthopaedic Surgery
• 18 yo NCAA D1 baseball pitcher• Intermittent knee pain for several
years• Never previously evaluated• No acute injury• Currently rehabbing s/p UCL
reconstruction• Exam:Moderate effusion FROMMild, vague TTP
anteromedially Normal ligamentous exam
Case Example
![Page 6: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/6.jpg)
University of Virginia Orthopaedic Surgery
Imaging
![Page 7: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/7.jpg)
University of Virginia Orthopaedic Surgery
Imaging
![Page 8: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/8.jpg)
University of Virginia Orthopaedic Surgery
Imaging
![Page 9: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/9.jpg)
![Page 10: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/10.jpg)
KneeOsteochondritis Dissecans
Osteochondritis Dissecans• Juvenile form (open physes)-
Better prognosis– Initial management conservative
(Non-weight bearing 6-12 weeks)
• Most commonly affects Lateral aspect of MFC
• Pathological changes begin in subchondral bone Tria, et al Illustrated Guide to the Knee
Churchill-Livingstone 1992
![Page 11: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/11.jpg)
KneeOsteochondritis DissecansCritical Treatment Considerations: Age / Skeletal Maturity***
Lesion Size Lesion Location Lesion Stability Lesion Viability
Other Factors (Aligment, Stability, etc.)
![Page 12: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/12.jpg)
University of Virginia Orthopaedic Surgery
Back to our case…
![Page 13: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/13.jpg)
University of Virginia Orthopaedic Surgery
![Page 14: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/14.jpg)
University of Virginia Orthopaedic Surgery
![Page 15: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/15.jpg)
University of Virginia Orthopaedic Surgery
Probing lesion (Video)
![Page 16: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/16.jpg)
University of Virginia Orthopaedic Surgery
Extended portal….
![Page 17: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/17.jpg)
University of Virginia Orthopaedic Surgery
![Page 18: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/18.jpg)
University of Virginia Orthopaedic Surgery
![Page 19: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/19.jpg)
University of Virginia Orthopaedic Surgery
![Page 20: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/20.jpg)
University of Virginia Orthopaedic Surgery
Imaging
![Page 21: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/21.jpg)
University of Virginia Orthopaedic Surgery
![Page 22: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/22.jpg)
University of Virginia Orthopaedic Surgery
![Page 23: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/23.jpg)
University of Virginia Orthopaedic Surgery
![Page 24: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/24.jpg)
![Page 25: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/25.jpg)
University of Virginia Orthopaedic Surgery
• 21yo NCAA D1 Women’s soccer player
• 18 months s/p ACLR• Insidious onset of lateral
knee pain and episodic swelling
Case Example
![Page 26: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/26.jpg)
University of Virginia Orthopaedic Surgery
Clinical Assessment
• History– Mechanism– Previous injuries– Previous symptoms– Previous surgeries– Instability?
• Symptoms– Pain, effusion, mechanical symptoms– Similar to meniscus tear
• Physical Exam– Joint effusion– Tenderness– Ligamentous exam– Alignment
![Page 27: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/27.jpg)
University of Virginia Orthopaedic Surgery
Radiographic Assessment
• Plain x-ray– Used to evaluate for alignment, bony defects
and presence/absence of arthritis– Include flexion PA view to evaluate for early
degenerative changes and merchant view to evaluate the patellofemoral joint
– Consider long limb standing films to evaluate alignment
• MRI– Most sensitive for evaluating focal cartilage
defects– Allows accurate assessment of chondral lesion,
edema, and any concomitant pathology including ligamentous or meniscal injury
![Page 28: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/28.jpg)
University of Virginia Orthopaedic Surgery
Description and Characterization
• Descriptive– Based on MRI (size, depth)
• Classification Systems
![Page 29: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/29.jpg)
University of Virginia Orthopaedic Surgery
Management
• Considerations– Duration and severity of symptoms– Concomitant injuries– Location of lesion– Depth of defect– Size (diameter) of defect– Patient age– History of trauma– Concomitant arthritis– Patient activity level/demands– Mechanical alignment/mal-alignment
![Page 30: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/30.jpg)
University of Virginia Orthopaedic Surgery
Management: Non-Surgical
• Potential option for small or asymptomatic lesions
• Includes rest, NSAIDs, therapy• +/- injections
– Corticosteroid injections, HA injections
• Goal is to reduce symptoms, not heal the lesion
• The lesion is unlikely to heal with conservative therapies
• Little data on natural history of such lesions in young individuals, but most suggest deterioration over time
![Page 31: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/31.jpg)
University of Virginia Orthopaedic Surgery
Management: Surgical
• Numerous options:– Arthroscopic Lavage and
Debridement– Abrasion Arthroplasty / Subchondral
Drilling/ Microfracture– Osteochondral Autograft /
Mosaicplasty– Osteochondral Allograft– ACI/MACI
![Page 32: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/32.jpg)
University of Virginia Orthopaedic Surgery
Debridement
• Early arthroscopic option for chondrallesions
• May remove loose flaps or edges that mechanically impinge in the joint
• Will not result in cartilage regeneration, but can improve symptoms
• Typically used more frequently for degenerative lesions
• Symptomatic improvement in 45% of patients, however only 68% of patients have prolonged improvement
![Page 33: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/33.jpg)
University of Virginia Orthopaedic Surgery
Microfracture, etc
• Marrow stimulation techniques include subchondral drilling and microfracture
• Technique includes debridement of lesion edges to create a contained crater
• Subchondral drilling involves use of a drill to perforate the bone and allow bleeding into the defect and clot formation
• Microfracture avoids the the thermal effects of a drill by using an arthroscopic awl to create several holes 3-4 mm apart
![Page 34: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/34.jpg)
University of Virginia Orthopaedic Surgery
• 22 yo WSOC– S/p slide tackle injury– Anterior knee pain– Mechanical catching– Effusion
Case Example
![Page 35: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/35.jpg)
University of Virginia Orthopaedic Surgery
Case Example
![Page 36: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/36.jpg)
University of Virginia Orthopaedic Surgery
Microfracture, etc
Outcomes• Steadman, et al 1997
– 75% with improvement at 5 years– 20% with stabilization of symptoms– 5% with deterioration
• Kreuz, et al 2006– All patients improved in first 18 months– Deterioration began at 18 months– More pronounced for age > 40
• Alparslan, et al 2007– Overall good improvement of function
and activitiy
![Page 37: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/37.jpg)
University of Virginia Orthopaedic Surgery
Microfracture, etc
![Page 38: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/38.jpg)
University of Virginia Orthopaedic Surgery
Osteochondral Autografting
• Indications:– Discrete, focal traumatic lesion– Weight bearing surface– Accessible– No diffuse arthritis– No “kissing” lesions
![Page 39: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/39.jpg)
University of Virginia Orthopaedic Surgery
Osteochondral Autografting
Like changing the pin location on the putting green!
![Page 40: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/40.jpg)
University of Virginia Orthopaedic Surgery
Osteochondral Autografting
• Technique– Diagnostic arthroscopy– Debridement of edges– Plan geometry– Harvest plugs– Insert plugs
• Superolateral• Notch• Superomedial• Opposite Knee
![Page 41: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/41.jpg)
University of Virginia Orthopaedic Surgery
Back to our case: 21yo WSOC Player
![Page 42: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/42.jpg)
University of Virginia Orthopaedic Surgery
Osteochondral Autografting
Outcomes• Gudas et al (Arthroscopy, 2005):
– 96% good to excellent, 93% return to sports.
• Ma HL et al (Injury, 2004): – 89% good to excellent.
• Lahav et al (J Knee Surg, 2006): – 86% “would do again”
• Macacci et al (Arthroscopy, 2005): – 78.3% success
![Page 43: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/43.jpg)
University of Virginia Orthopaedic Surgery
Osteochondral ALLOgrafting
• Similar to autografting, but may be used for medium to large, full thickness defects
• Avoids donor site morbidity and size limitations of autograft
• Fresh allograft– Higher chondrocyte availability– Higher risk for disease transmission
• Cryopreserved frozen allografts– Reduced immunogenicity and disease– Lower chondrocyte availability
![Page 44: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/44.jpg)
University of Virginia Orthopaedic Surgery
ACI/MACI
• Multi-step procedure– Diagnostic arthroscopy and cartilage harvest– Chondryocyte cultivation in laboratory– Implantation surgery (6 weeks later)– ACI uses periosteal flap for injection of
chondrocytes– MACI uses collagen membrane and fibrin
glue
• Indications– Younger, active patients– Isolated traumatic femoral defect– Must correct ligamentous and meniscal
lesions, joint malalignment and patellofemoral instability
![Page 45: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/45.jpg)
University of Virginia Orthopaedic Surgery
ACI/MACI
Outcomes• 89% G/E results in focal femoral
condyle lesions, 75% in ACL reconstructed patients (1998)
• In a series of 891 patients, G/E results in 86%, with 12.6% complication rate
• Failure rate around 6% at 2 years
![Page 46: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/46.jpg)
![Page 47: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/47.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
• 22 year old male collegiate basketball athlete presents with left knee pain
• Symptoms present for approximately one week
• He reports swelling, anterolateral tenderness and mechanical symptoms including catching with activity
• At time of injury, in pre-season practice, season starting in ~ 6 weeks
![Page 48: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/48.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
• PMH: none pertinent. denies previous left knee injury
• PSH: – right ankle lateral ligament
reconstruction 2 years earlier– left hip arthroscopy
• Exam:– 2+ effusion– Lateral joint line tenderness– No instability– Negative McMurray
![Page 49: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/49.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
![Page 50: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/50.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
![Page 51: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/51.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
PLAN?• 22 year old• D1 basketball player, starting
point guard, senior year• Full thickness lesion• 6 x 11 mm size• Plan? • Arthroscopy, OAT if possible,
microfracture if not
![Page 52: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/52.jpg)
University of Virginia Orthopaedic Surgery
Case Presentation
• After debridement, 8 x 15 mm• 2 plugs (one 8mm, one 6mm)• Returned to sport in 44 days
![Page 53: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/53.jpg)
C. Jan Gilmore, MDChris T. Cosgrove, BS
Brian Werner, MDEric W. Carson, MDMark D. Miller, MD
Stephen F. Brockmeier, MDDavid R. Diduch, MD
![Page 54: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/54.jpg)
University of Virginia Orthopaedic Surgery
Study Design
• Methods:• Retrospective chart review• Institutional cohort of 152 OAT procedures• All patients from 2000-present reviewed• 20 athletes identified in this cohort
• Athlete Cohort• Isolated OAT procedure for knee• Excluded if concomitant ligament or
meniscal procedure• All underwent physician-directed
accelerated progression and return to sports
• Evaluated for progression, time to return to sport and clinical outcomes
![Page 55: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/55.jpg)
University of Virginia Orthopaedic Surgery
Results
• Demographics• Average age 21.6 yrs• 70% male• Avg. lesion size: 134 mm2 [15 – 280 mm2]• Avg. # of plugs: 2.15 [1 – 4 plugs]
• Average plug size: 6.72 mm [4 – 10]• MFC lesions: 8• LFC lesions: 12
# of plugs # of patients
1 plug 5
2 plugs 9
3 plugs 4
4 plugs 2
![Page 56: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/56.jpg)
University of Virginia Orthopaedic Surgery
Results
• Outcomes• Average 4.4 years follow-up [1.3 - 6.9]• IKDC: 84.5 ± 9.5• Pre-Injury Tegner: 8.9 ± 1.7• Post-op Tegner: 7.7 ± 1.9• Satisfaction: 100% (satisfied
or very satisfied)
![Page 57: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/57.jpg)
University of Virginia Orthopaedic Surgery
Results
• Outcomes• Avg. time to release: 83.9 days [39 – 134 days]• # requiring reoperation: 0• # with pain @ release or later: 5 (25%)• # with effusions @ release or later: 4 (20%)• # requiring injection @ release or later: 4 (20%)• # with mechanical symptoms @ release: 0
![Page 58: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/58.jpg)
University of Virginia Orthopaedic Surgery
Return to Sports
![Page 59: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/59.jpg)
University of Virginia Orthopaedic Surgery
Return to Sports
Systematic review of 1363 patients:• Microfracture: 8 ± 1 months• Osteochondral autograft: 7 ± 2 months• Osteochondral allograft: 10 months• ACI: 18 ± 4 months• OAT had highest RTS for athletes (91%) as
well as highest durability of pre-injury level of performance (96%)
Second review of 658 patients:• Microfracture: 59% RTS, 17 months• OAT: 93% RTS, 6.5 months• ACI: 78% RTS, 25 months
![Page 60: Stephen F. Brockmeier, MD · knee. 2. To critically review the current literature and ... Speaker – Zimmer Biomet, Depuy, Arthrex Clinical Trial (active) – Zimmer Biomet Publishing](https://reader036.vdocument.in/reader036/viewer/2022070702/5e6dbd29aeeed042f6516f93/html5/thumbnails/60.jpg)